Silla L, Valim V, Pezzi A, da Silva M, et al. Adoptive immunotherapy with double-bright (CD56(bright) /CD16(bright) ) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study. Br J Haematol 2021;195:710-721.
PMID: 34490616